Zurueck zur Suche

Reporte zur Charge SN6205

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 LA 1

VAERS 1756327

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge SN6205

mild
Staat
NY
Alter
72,0
Geschlecht
U
Eingang
02.10.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Body temperature Decreased appetite Fatigue Headache Pain Pyrexia SARS-CoV-2 test

Symptomtext

Fever of 100-100.4; tired; headache; achey; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient) in response to non-HCP letter sent in cross-reference case. A 72-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: SN6205, patient was 72-yeear-oldat the time of vaccination), via intramuscular route of administration, administered in Arm Left on 03Mar2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included migraine and Hashimoto. Concomitant medication(s) included diclofenac (DICLOFENAC) taken for migraine from an unspecified start date and ongoing 2 days prior; levothyroxine sodium (SYNTHROID) taken for autoimmune thyroiditis from an unspecified start date and ongoing; liothyronine sodium (CYTOMEL) taken for autoimmune thyroiditis from an unspecified start date and ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EL9624), via intramuscular route of administration, administered in Arm Left on 10Feb2021 at 08:22 AM as DOSE 1, SINGLE for covid-19 immunisation and experienced hot/cold, achy, tired, headache, fever all on 11Feb2021 for 4 days with outcomes of events were recovered without any treatment. No prior Vaccinations received. On 03Mar2021, the patient experienced fever of 100-100.4, tired, headache, achey, loss of appetite for 5 days (Outcome unknown for events). The patient underwent lab tests and procedures which included body temperature: 100 - 100.4 on 03Mar2021, sars-cov-2 test: negative on 05Mar2021. No treatment received for Fever and required urgent care on 05Mar2021. The outcome of event (fever of 100-100.4) was recovered on an unspecified date in 2021 and the outcomes of events (tired, headache, achey, loss of appetite) were unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Test Date: 20210303; Test Name: fever; Result Unstructured Data: Test Result:100 - 100.4; Test Date: 20210305; Test Name: SARS-CoV-2 Rapid ag Covid-19; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Hashimoto's disease; Migraine
Andere Medikamente
Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034
Allergien
-
Vorherige Impfungen
-

VAERS 1692667

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge SN6205

mild
Staat
LA
Alter
61,0
Geschlecht
F
Eingang
11.09.2021
Impfdatum
28.02.2021
Beginn
02.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Peripheral swelling Pruritus

Symptomtext

swollen and itchy arm; swollen and itchy arm; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in right arm on 28Feb2021 15:00 (at the age of 61-year-old)(Batch/Lot Number: SN6205) as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of bnt162b2 for covid-19 immunisation on 07Feb2021. On 02Mar2021, the patient experienced swollen and itchy arm. The patient did not received treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-